Prognostic value of the Hippo pathway transcriptional coactivators YAP/TAZ and β1-integrin in conventional osteosarcoma

Corinne Bouvier(Centre National de la Recherche Scientifique), Sébastien Salas(Assistance Publique Hôpitaux de Marseille)
Oncotarget
September 6, 2016
10.18632/oncotarget.11876
Cited by 55

Related Papers

Efficacy and Safety of Nivolumab Plus Ipilimumab vs Nivolumab Alone for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
|JAMA Oncology|2023|73
Correlation between ERK1 and STAT3 expression and chemoresistance in patients with conventional osteosarcoma
|BMC Cancer|2014|29